An antibiotic that has shown effectiveness for bacterial pneumonia also appears successful in fighting methicillin-resistant staph infections, reports a team led by Duke Health.
Sep 28, 2023
0
9
In eastern Africa, malaria parasites have developed resistance to artemisinins, the backbone of current treatment regimens, a development that could dramatically worsen malaria's impact if partner drugs fail in the future.
Sep 27, 2023
0
35
According to a new international study, cleft palate surgery at the age of 6 months provides better conditions for speech and language development compared to surgery at 12 months. The results were published in the New England ...
Sep 25, 2023
0
10
Dabrafenib plus trametinib results in significantly more responses and longer progression-free survival than standard chemotherapy for pediatric patients with low-grade glioma with BRAF V600 mutations, according to a study ...
Sep 21, 2023
0
16
For outpatients with mild-to-moderate COVID-19, inhaled fluticasone furoate does not shorten time to symptom resolution, according to a study published in the Sept. 21 issue of the New England Journal of Medicine.
Sep 21, 2023
0
32
The classic computer science adage "garbage in, garbage out" lacks nuance when it comes to understanding biased medical data, argue computer science and bioethics professors from MIT, Johns Hopkins University, and the Alan ...
Sep 14, 2023
0
56
The immunotherapy agent atezolizumab induces sustained responses in about one-third of patients with advanced alveolar soft part sarcoma (ASPS), according to a study published in the Sept. 7 issue of the New England Journal ...
Sep 8, 2023
0
26
It's a worst-case scenario in health care: A patient undergoes life-saving surgery and is sent home to recover, only to return to hospital later with a surgical site infection.
Sep 8, 2023
0
1
The lethal mixture of xylazine and fentanyl, also known as Tranq dope, may sound unfamiliar to many, but its impact is harming people who use drugs nationwide.
Sep 8, 2023
0
15
Treating newly diagnosed type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.
Sep 6, 2023
1
112
